KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teladoc Health (TDOC) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Teladoc Health (TDOC) over the last 12 years, with Q3 2025 value amounting to -$48.7 million.

  • Teladoc Health's Cash from Investing Activities fell 5641.45% to -$48.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$261.3 million, marking a year-over-year decrease of 9961.81%. This contributed to the annual value of -$124.1 million for FY2024, which is 2065.6% up from last year.
  • As of Q3 2025, Teladoc Health's Cash from Investing Activities stood at -$48.7 million, which was down 5641.45% from -$59.7 million recorded in Q2 2025.
  • Teladoc Health's Cash from Investing Activities' 5-year high stood at -$2.2 million during Q2 2021, with a 5-year trough of -$123.3 million in Q1 2025.
  • Moreover, its 5-year median value for Cash from Investing Activities was -$36.5 million (2023), whereas its average is -$39.6 million.
  • As far as peak fluctuations go, Teladoc Health's Cash from Investing Activities soared by 9515.01% in 2021, and later tumbled by 196812.73% in 2022.
  • Over the past 5 years, Teladoc Health's Cash from Investing Activities (Quarter) stood at -$20.1 million in 2021, then tumbled by 168.45% to -$53.9 million in 2022, then skyrocketed by 32.26% to -$36.5 million in 2023, then increased by 18.8% to -$29.6 million in 2024, then crashed by 64.35% to -$48.7 million in 2025.
  • Its Cash from Investing Activities stands at -$48.7 million for Q3 2025, versus -$59.7 million for Q2 2025 and -$123.3 million for Q1 2025.